Erica L. Bradshaw
OAI Consulting (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism, Smoking Behavior and Cessation, Synthesis and biological activity, HER2/EGFR in Cancer Research
Most-Cited Works
- → Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities(2019)87 cited
- → P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing(2005)36 cited
- → Rapid and sensitive LC/MS/MS analysis of the novel tyrosine kinase inhibitor ZD6474 in mouse plasma and tissues(2005)30 cited
- → Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile(2020)12 cited
- → Antismoking Interventions in Residential Substance Abuse Treatment(2009)2 cited
- → Role of Data in Development and Application of Quantitative Systems Pharmacology Models(2025)